GET A PIECE OF CALIBRE BIOMETRICS
Unlock the data in your breath
$70,272.44 Raised
Reasons to Invest
- Differentiated and protected technology - Calibre provides scalable access to accurate and informative respiratory data that was previously only available in labs or hospitals. This is achieved with an innovative, wearable product that can be used by anyone, enabled by revolutionary technology that is protected by multiple patents.
- Early move in greenfield space - We believe Calibre to be one of the first to bring breath-based wearables to the consumer market in a scalable way - democratizing access to respiratory data, and in doing so establishing an entirely new - and very large - space in the digital health data market.
- Remarkable upside opportunity - Calibre’s founding team has successfully taken the product through development, manufacturing, and beta testing - and is now shipping regularly to customers - all on a relatively shoestring budget, allowing Calibre to offer a ground-floor investment opportunity with enormous upside.
Overview
The future of respiratory data is Calibre
Respiratory data has been enormously interesting to medical science but out of reach for most people. At Calibre, we aim to provide an accessible way for anyone to track and collect this data whenever and wherever they would like to. The implications are groundbreaking and amazing.
Combining established respiratory science with breakthrough technology, we believe Calibre empowers users to take charge of their metabolism, respiratory wellness, and much more.
Through our game-changing design and technology, Calibre enables respiratory data access to anyone, simply, on a cloud-enabled app. In other words, we are unlocking a hidden trove of personal metabolic and physiological data for millions.
THE Problem & OUR solution
Biometrics of human breath have been appreciated for over a century, but the data has been out of reach for most people
Breath data has been historically only accessible for professional use in laboratory settings, utilizing expensive, cumbersome, complex equipment.
Calibre solves all these issues, thereby unleashing a whole new market.
Proven science shows all our calories are “burned” using oxygen and producing CO2 - that’s breath! Calibre makes this established insight available to everybody - accurately tracking calories used per minute by measuring the oxygen and C02 in exhaled breath. It can even distinguish fat burn from carb burn, isn’t that cool? And perhaps most remarkable, this works in any activity and for any body type. All on your phone, anytime you want.
We are aware that respiratory monitoring machines have been available for years, but they can cost from $10k upwards to $100k - where at Calibre our device is under $400 and usable anywhere. Currently, we are engaged in a B2C model that provides 1:1 sales; however, it is our goal to also offer our products at a large scale through institutions, sports programs, and various partnerships.
Act 2 - Medical Use
Calibre provides an easy way for breath data to be collected securely in real-time to the cloud. As such, we feel Calibre can become extremely beneficial in medical and clinical settings in the not-too-distant future. Calibre could provide caregivers remote patient monitoring capabilities for a range of conditions and purposes ranging from pulmonary and cardiovascular health to sleep and neurological issues. We also believe that Calibre can be a powerful tool for clinical research on a new scale, in terms of what and how participants, can be studied using Calibre devices. At the moment Calibre is not an FDA-approved medical device, but we are planning to apply for FDA clearance in the near future.
The market & Our Traction
The wearables market was valued at more than $100 Billion in 2021* - we believe Calibre is positioned to be an industry leader in its sector
In this expanding market, we feel there has been a glaring absence of products to monitor and track respiratory data. Calibre's technology has the potential to fill that gap and offer key insights through the data collected.
The global wearable technology market size is projected to grow at a compound annual growth rate of 13.89% to reach around $392.4 Billion during the forecast period of 2022 to 2030 (source), and wearable devices specifically in consumer applications could skyrocket up to $212.67 Billion by 2029 (source).
Calibre aims to be an industry leader in these growing markets, and we believe we have made significant headway towards that goal. In anticipation of such potential, we have filed multiple patents (8 pending, one already issued).
Here’s a look at more of our traction...
WHY INVEST
Calibre is on a mission to expand and make respiratory data more accessible for all
We feel that Calibre is poised to disrupt the wearables and digital health market, and believe that our technology's application can expand tremendously with the financial support we need to get there.
Our longer-term vision is to “get serious” about the medical opportunities - moving towards FDA certification, hiring the right experts, and, above all, engaging the medical community.
Calibre is bringing something unique, novel, affordable, and accessible to the market - we believe everyone can have access to their respiratory data through user-friendly wearable technology. Join in on the mission and invest today!
ABOUT
HEADQUARTERS
35 Walnut Street, Suite 100
Wellesley Hills, MA 02481
WEBSITE
View Site
Calibre® is on a mission to democratize access to respiratory and metabolic data. By revolutionizing breath measurement through our affordable, ultralight wearable device, we believe we can make respiratory data available to millions with applications for fitness training, wellness, and eventually a wide variety of medical uses. Our product has recently been launched and is now shipping to customers.
TEAM
Udi Meirav
CEO and Founder
Raviv Shefet
Chief Financial Officer
David Ierardi
Chief Operating Officer
Sean Coakley
Marketing and Business Development
James Ciriello
Director
TERMS
Calibre Biometrics
Overview
PRICE PER SHARE
$2.50
DEADLINE
Mar 21, 2023
VALUATION
$22.75M
FUNDING GOAL
$15k - $1.24M
Breakdown
MIN INVESTMENT
$500
MAX INVESTMENT
$1,235,000
MIN NUMBER OF SHARES OFFERED
6,000
MAX NUMBER OF SHARES OFFERED
494,000
OFFERING TYPE
Equity
SHARES OFFERED
Class A Common Stock
Maximum Number of Shares Offered subject to adjustment for bonus shares
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives and Bonuses*
Time-Based:
Friends and Family Early Birds
Invest within the first 96 hours and receive 20% bonus shares.
Super Early Bird Bonus
Invest within the first week and receive 15% bonus shares.
Early Bird Bonus
Invest within the first three weeks and receive 10% bonus shares.
Amount-Based:
$1000 + / Supporter
Invest $1,000 and receive 2% Bonus Shares.
$2,500+ | VIP
Invest $2,500 + and receive 5% Bonus Shares.
$5,000 + | VIP + 10 % Bonus Shares
Invest $5,000+ and receive 10 % Bonus Shares, Free product.
$10,000+ | VIP Gold
Invest $10,000+ and receive 15% Bonus Shares, Free product, coaching session with Sean (Co-Founder/Master Instructor).
$25,000+ | VIP Platinum
Invest $25,000+ and receive 20% Bonus Shares + Private zoom call with Chief Executive Officer, Free product, coaching session with Sean (Co-Founder/Master Instructor).
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
Calibre Biometrics Inc. will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Class A Common Stock at $2.50 / share, you will receive 110 shares of Class A Common Stock, meaning you'll own 110 shares for $250. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
Irregular Use of Proceeds
The Company might incur Irregular Use of Proceeds that may include but are not limited to the following over $10,000: Vendor payments.
ALL UPDATES
Stack Owner's Bonus & Rewards!
Members get an extra 10% shares in addition to rewards below!
REWARDS
JOIN THE DISCUSSION
0/2500
Kevin Fulmer
7 months ago
Hi Udi - I can't respond to your comment directly for some reason, but send me an email at hellocrowdscale@gmail.com
0
0
Kevin Fulmer
7 months ago
Hi Udi - following up on my below questions.
1
0
Khaleedow Bright
8 months ago
Hello, I'm Khaleedow, an expert in fundraising. I came across your campaign and see that it is not getting enough investments because it is missing out on a crucial component which is Organic promotion.
I can help you promote your campaign organically and make it reach real and active investors who will be interested and willing to invest in your campaign.
You can reach me out or contact me through this link below
https//www.fiverr.com//khaleed011
0
0
Kevin Rivera
8 months ago
Can you please share some revenue goals for the next 5 years?
1
0
Kevin Fulmer
8 months ago
Hi Udi - this looks like a super interesting concept! I have a few questions before deciding to invest:
1. What are the metrics that this can track that the Apple Watch cannot?
2. Can you connect your data to your apple watch?
3. Who is the main customer for this, fitness junkies or older people monitoring respiratory issues?
4. Can you explain the compensation of your CEO? It says he is paid $280k/year, but that he is just accruing that amount and not extracting actual cash from the business right now.
5. What is your monthly cash burn?
6. How much do these cost to produce, and what is your profit margin?
7. Who are your direct competitors that are also selling a breath-tracking device?
8. How many orders have you received thus far?
1
1
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Ronnie Jaikaran
6 months ago
0
0